ISR Share Price

Open 0.54 Change Price %
High 0.55 1 Day 0.02 3.77
Low 0.52 1 Week 0.01 1.85
Close 0.55 1 Month -0.08 -12.70
Volume 143025 1 Year -0.12 -17.91
52 Week High 1.30
52 Week Low 0.48
ISR Important Levels
Resistance 2 0.58
Resistance 1 0.57
Pivot 0.54
Support 1 0.53
Support 2 0.52
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
NAK 2.26 0.00%
NAK 2.26 0.00%
CVM 0.10 -16.67%
CVM 0.10 -16.67%
NGD 3.09 -2.52%
NGD 3.09 -2.52%
PLX 1.08 -6.90%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
CHGS 0.01 -66.67%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
MCZ 0.08 -20.00%
MCZ 0.08 -20.00%
More..

IsoRay, Inc. (AMEX: ISR)

ISR Technical Analysis 5
As on 17th Feb 2017 ISR Share Price closed @ 0.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.76 & Strong Sell for SHORT-TERM with Stoploss of 0.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
ISR Target for February
1st Target up-side 0.68
2nd Target up-side 0.74
3rd Target up-side 0.8
1st Target down-side 0.52
2nd Target down-side 0.46
3rd Target down-side 0.4
ISR Other Details
Segment EQ
Market Capital 20927304.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.isoray.com
ISR Address
ISR
350 Hills Street
Suite 106
Richland, WA 99354
United States
Phone: 509-375-1202
ISR Latest News
IsoRay Medical, Inc. Discusses Cesium-131 and its Applications in New SNNLive ...   PR Newswire (press release)   - 22nd Dec 16
IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative ...   PR Newswire (press release)   - 21st Dec 16
IsoRay Announces "Cesium-131 Brachytherapy for Salvage of Recurrent High Grade ...   PR Newswire (press release)   - 29th Nov 16
IsoRay, Inc. Announces Date for Fiscal 2017 Annual Meeting and Shareholder ...   PR Newswire (press release)   - 21st Oct 16
IsoRay® Announces Results of Prospective Trial Presented at Society of Neuro ...   PR Newswire (press release)   - 21st Jun 16
IsoRay, Inc. Announces Annual Meeting and Shareholder Record Dates   PR Newswire (press release)   - 09th Apr 16
IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15   PR Newswire (press release)   - 14th Jan 16
IsoRay Chairman and CEO Dwight Babcock to Retire   PR Newswire (press release)   - 07th Jan 16
Why I Believe IsoRay Is Overvalued By At Least 40% From Its Current Price ($1 ...   Seeking Alpha   - 21st Mar 14
Why IsoRay Presents A Very Compelling Risk/Reward Opportunity   Seeking Alpha   - 14th Mar 14
Interactive Technical Analysis Chart IsoRay, Inc. ( ISR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on IsoRay, Inc.
ISR Business Profile
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.